1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveNational Institute on Drug Abuse (NIDA) · 2026

Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed)

Quick Facts

Agency: National Institute on Drug Abuse (NIDA)
Funding: See official notice
Deadline: Check Source
Status: Active
Eligibility: See official notice

About This Grant

Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) is sponsored by National Institute on Drug Abuse (NIDA). This opportunity supports mission-aligned projects and measurable outcomes.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) - Federal Grant Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) The summary for the Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) grant is detailed below.

This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .

If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed): The purpose of this FOA is to support basic research on signaling pathways and mechanisms including HIV-host protein interactions and post-translational modifications by which addictive drugs and HIV infection converge to induce changes in brain function and cause neuropathological alterations and neurocognitive dysfunctions.

This FOA also aims to promote discovery and development of novel chemical and biological approaches for prevention or mitigation of CNS complications associated with HIV infection and substance use disorders.

Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) National Institutes of Health (HHS-NIH11) Funding Opportunity Number: Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)

Additional Information on Eligibility Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Link to Full Grant Announcement https://grants. nih. gov/grants/guide/rfa-files/RFA-DA-24-013.

html Grant Announcement Contact See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. Similar Government Grants • Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...

• Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship an... • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) • Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H... • Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeu...

• NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards • Drug Abuse Aspects of Hiv/Aids and Other Infections • Epidemiology of Drug Abuse More Grants from the National Institutes of Health • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...

• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ... • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) • Silvio O.

Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5... Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance

Eligibility Requirements

See official notice

Frequently Asked Questions

Who can apply for Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed)?

According to the current listing, eligibility includes: See official notice. Confirm the full requirements in the official notice before applying.

Who funds Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed)?

Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) is funded by National Institute on Drug Abuse (NIDA). Verify program details on the funder's official page before applying.

How do I apply for Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed)?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Related Grants

National Institute on Drug Abuse (NIDA)

DiscoveredActive

Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)

Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) is sponsored by National Institute on Drug Abuse (NIDA). This program aims to support the development of educational courses that provide researchers with the skills necessary to translate their research on drug use and addiction into practical applications.

Not specifiedDeadline: Oct 2, 2026

National Institute on Drug Abuse (NIDA) Grant Writing Tips

NIH's HEAL Initiative Will Fund Your Non-Opioid Painkiller at Its Riskiest Stage: R61/R33 Analgesic Discovery, $350K a Year, September 17 Deadline

The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.

Read article

ARPA-H's FASTPASS Wants to X-Ray Your Medicine Without Opening the Box — the Solicitation Drops in Mid-August

ARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.

Read article

The Federal Government Is Spending $144 Million to Crack the Code on Aging. Here Are the Seven Teams Racing to Do It.

ARPA-H PROSPR program funds seven research teams testing rapamycin, semaglutide, and novel compounds to extend healthspan. A deep analysis of the science, the money, and what it means for the field.

Read article